Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.20.2
STOCKHOLDERS' EQUITY (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
May 06, 2020
Jan. 31, 2020
Aug. 30, 2019
Jun. 30, 2020
Jun. 30, 2020
Dec. 31, 2018
Dec. 31, 2019
STOCKHOLDERS' EQUITY (Details) [Line Items]              
Preferred stock, authorized       10,000,000 10,000,000   10,000,000
Preferred stock, par value (in Dollars per share)       $ 0.0001 $ 0.0001   $ 0.0001
Common stock, authorized       350,000,000 350,000,000   350,000,000
Common stock, par value (in Dollars per share)       $ 0.0001 $ 0.0001   $ 0.0001
Common stock, outstanding       59,268,085 59,268,085   59,268,085
Common stock, issued       59,268,085 59,268,085   59,268,085
Number of shares to purchase by stock option   19,625 24,428,681        
Common stock reserved for issuance       10,000,000 10,000,000    
Amount of shares to purchase by stock option (in Dollars)   $ 15,479          
Weighted-average contractual remaining life         9 years 10 months 24 days    
Restricted stock purchase         3,000,000    
StockOptions [Member]              
STOCKHOLDERS' EQUITY (Details) [Line Items]              
Stock compensation expense (in Dollars)       $ 737,306 $ 752,785    
Stock options to purchase 1,499,000     1,499,000 1,499,000    
Stock options exercise price (in Dollars per share) $ 2.13            
Stock option exercise price, decrease (in Dollars per share)         $ 2.13    
Stock option exercise price, increase (in Dollars per share)         $ 2.133    
Unrecognized compensation expense (in Dollars)       $ 382,000 $ 382,000    
Expected weighted average vesting period         1 year 9 months 18 days    
Restricted Stock Units (RSUs) [Member]              
STOCKHOLDERS' EQUITY (Details) [Line Items]              
Vesting period         2 years    
Stock compensation expense (in Dollars)         $ 1,050,000    
Unrecognized compensation expense (in Dollars)       $ 7,350,000 $ 7,350,000    
Expected weighted average vesting period         3 months    
Restricted stock purchase           378,478  
Shares options issued non-vested       2,625,000 2,625,000    
Weighted average grant-date fair value of exercise price (in Dollars per share)         $ 2.80    
Weighted-average contractual remaining life         1 year 9 months    
Non vested restricted shares       47,308 47,308    
Weighted average grant-date fair value (in Dollars per share)         $ 0.22    
Vesting period         2 years    
Unrecognized compensation expense, unvested portion (in Dollars)       $ 10,117 $ 10,117    
StockOptions [Member] | Issue price three [Member]              
STOCKHOLDERS' EQUITY (Details) [Line Items]              
Number of shares to purchase by stock option 694,625            
Warrants [Member]              
STOCKHOLDERS' EQUITY (Details) [Line Items]              
Vesting period 5 years            
Stock compensation expense (in Dollars)       83,654      
Warrants outstanding         5,639,167    
Weighted-average contractual remaining life         2 years 8 months 12 days    
Exercise prices decrease (in Dollars per share)         $ 0.01    
Exercise prices increase (in Dollars per share)         3.25    
Weighted average exercise price (in Dollars per share)         $ 3.05    
Warrants [Member] | Issue price One [Member]              
STOCKHOLDERS' EQUITY (Details) [Line Items]              
Warrants to purchase shares 143,750            
Warrants exercise price (in Dollars per share) $ 2.50            
Warrants [Member] | Issue price two [Member]              
STOCKHOLDERS' EQUITY (Details) [Line Items]              
Warrants to purchase shares 29,375            
Warrants exercise price (in Dollars per share) $ 2.13            
Warrants [Member] | Issue price three [Member]              
STOCKHOLDERS' EQUITY (Details) [Line Items]              
Warrants to purchase shares 694,625            
Warrants exercise price (in Dollars per share) $ 2.50            
Consultant [Member] | Restricted Stock Units (RSUs) [Member]              
STOCKHOLDERS' EQUITY (Details) [Line Items]              
Stock compensation expense (in Dollars)       $ 10,120 $ 20,240